tradingkey.logo
tradingkey.logo
Search

Janux Therapeutics Inc

JANX
Add to Watchlist
16.680USD
+0.160+0.97%
Close 09-24 16:00(ET)
1.02BMarket Cap
LossP/E TTM

JANX Financials

See Janux Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.02B
Dividend TTM
0.00
P/E TTM
-9.04
EPS TTM
-1.84
Revenue
10.00M
Net Profit
-68.99M
ROE
-11.72%
ROA
-11.01%

Janux Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.35/-0.38
Revenue / Forecast
10.27M/16.49M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
36.17%-0.35
-2.18%-0.39
-44.57%-0.51
23.68%-0.39
-399.78%-0.55
-26.43%-0.38
-41.26%-0.36
-102.95%-0.51
73.85%-0.11
28.02%-0.30
34.84%-0.25
---0.25
---0.42
---0.42
---0.39
---1.13
----
----
----
----
Revenue
--10.27M
--3.73M
--0.00
2177.90%10.00M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-82.56%439.00K
741.72%8.90M
-38.87%1.25M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
76.05%2.84M
56.43%1.81M
390.66%2.37M
318.16%1.59M
--1.62M
--1.16M
Net Profit
35.11%-21.97M
-3.63%-24.36M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-19.75%-16.07M
-55.08%-16.70M
-172.12%-16.89M
-487.13%-13.41M
-710.63%-13.42M
-757.17%-10.77M
Net Margin
---214.01%
---652.59%
----
96.20%-243.13%
----
----
----
-1290.70%-6391.57%
95.96%-66.98%
-38.29%-1178.91%
15.39%-477.77%
---459.59%
---1656.39%
---852.49%
---564.67%
---814.88%
----
----
----
----
Gross Margin
--100.00%
--100.00%
----
0.00%100.00%
----
----
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
Revenue
--10.27M
--3.73M
--0.00
2177.90%10.00M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-82.56%439.00K
741.72%8.90M
-38.87%1.25M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
76.05%2.84M
56.43%1.81M
390.66%2.37M
318.16%1.59M
--1.62M
--1.16M
Operating profit
29.76%-31.69M
1.96%-34.21M
-46.10%-42.40M
1.65%-35.25M
-226.42%-45.12M
-73.09%-34.90M
-79.85%-29.02M
-126.66%-35.84M
33.38%-13.82M
0.59%-20.16M
11.66%-16.14M
12.26%-15.81M
-20.20%-20.75M
-49.76%-20.28M
-35.40%-18.27M
-65.29%-18.02M
-176.09%-17.26M
-492.91%-13.54M
-715.11%-13.49M
-768.07%-10.90M
Net Profit
35.11%-21.97M
-3.63%-24.36M
-58.02%-31.95M
13.35%-24.31M
-468.18%-33.86M
-59.27%-23.51M
-71.93%-20.22M
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-19.75%-16.07M
-55.08%-16.70M
-172.12%-16.89M
-487.13%-13.41M
-710.63%-13.42M
-757.17%-10.77M
Current assets
-2.21%983.34M
-2.08%1.00B
-5.59%975.89M
49.79%998.09M
51.91%1.01B
55.37%1.02B
195.97%1.03B
87.59%666.32M
114.01%661.94M
104.94%658.67M
5.05%349.24M
3.16%355.19M
-13.62%309.30M
-11.86%321.40M
-11.82%332.44M
-11.62%344.33M
-9.72%358.06M
410.68%364.65M
--377.02M
--389.59M
Total current liabilities
181.36%60.15M
236.62%58.91M
43.18%25.00M
62.06%27.83M
85.18%21.38M
64.97%17.50M
33.96%17.46M
18.67%17.17M
-35.52%11.54M
-34.16%10.61M
-21.05%13.03M
-11.41%14.47M
37.79%17.90M
28.76%16.11M
28.99%16.51M
30.98%16.34M
41.16%12.99M
81.53%12.52M
--12.80M
--12.47M
Total assets
-2.38%1.01B
-2.15%1.03B
-5.65%1.00B
47.44%1.02B
49.29%1.03B
52.51%1.05B
179.05%1.06B
79.66%695.02M
102.46%691.41M
95.20%688.98M
4.50%380.41M
2.95%386.85M
-11.38%341.50M
-4.24%352.96M
-4.16%364.01M
-3.92%375.76M
-2.89%385.37M
413.23%368.60M
--379.82M
--391.08M
Total liabilities
91.07%79.67M
126.33%86.69M
15.51%44.74M
23.89%48.21M
23.60%41.70M
15.30%38.30M
7.42%38.73M
2.67%38.91M
-19.74%33.73M
-20.32%33.22M
-16.67%36.06M
-14.33%37.90M
1.16%42.03M
233.14%41.69M
220.59%43.27M
208.66%44.24M
245.45%41.55M
11.30%12.52M
--13.50M
--14.33M
Total equity
-6.31%927.98M
-7.01%941.53M
-6.45%956.82M
48.84%976.55M
50.61%990.52M
54.40%1.01B
197.02%1.02B
88.02%656.10M
119.61%657.68M
110.68%655.76M
7.36%344.35M
5.26%348.95M
-12.90%299.47M
-12.59%311.26M
-12.44%320.74M
-12.01%331.51M
-10.65%343.81M
487.84%356.08M
--366.33M
--376.75M
Net operating income
152.43%12.48M
27.53%-12.34M
-70.65%-28.54M
-476.24%-12.86M
-137.63%-23.81M
-14.74%-17.02M
-68.92%-16.73M
80.95%-2.23M
33.43%-10.02M
-6.66%-14.84M
16.89%-9.90M
12.71%-11.71M
-147.88%-15.05M
-20.73%-13.91M
-13.66%-11.91M
-129.14%-13.41M
2.11%-6.07M
-307.12%-11.52M
-543.40%-10.48M
-440.54%-5.85M
Net investment
-2582.97%-38.78M
102.43%8.29M
-12.92%29.54M
-34.46%8.31M
100.82%1.56M
-199.28%-340.39M
205.01%33.93M
120.62%12.67M
-1167.95%-190.88M
-1201.33%-113.74M
793.45%11.12M
-410.94%-61.45M
97.74%17.87M
-128.13%-8.74M
-121.89%-1.60M
109.62%19.76M
106.34%9.04M
20405.88%31.07M
--7.33M
---205.54M
Net financing
134.80%2.24M
539.89%3.54M
-99.24%2.94M
-70.10%493.00K
-65.50%954.00K
-99.83%554.00K
46428.28%386.65M
-97.09%1.65M
423.67%2.77M
20290.57%322.17M
335.08%831.00K
--56.61M
71.43%528.00K
157900.00%1.58M
16.46%191.00K
100.00%0.00
-99.91%308.00K
-100.00%1.00K
-96.40%164.00K
-2454.55%-843.00K

FAQs

What is the total revenue of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its total revenue reached 10.00M, with a year-on-year change of 10.59M.

What are the current assets of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its current assets were 975.89M, with a year-on-year change of -5.59.

What are the total assets of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its total assets of Janux Therapeutics Inc were 1.00B, with a year-on-year change of -5.65.

What are the total liabilities of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its total liabilities of Janux Therapeutics Inc were 44.74M, with a year-on-year change of 15.51.

What is the total equity of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its total equity of Janux Therapeutics Inc was 956.82M, with a year-on-year change of -6.45.

What is the net operating income of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its net operating income of Janux Therapeutics Inc was -157.67M, with a year-on-year change of -59.51.

What is the net investment of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its net investment of Janux Therapeutics Inc was -300.98M, with a year-on-year change of -16.65.

What is the net financing of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its net financing of Janux Therapeutics Inc was 4.95M, with a year-on-year change of -99.31.

What is the Earnings Per Share (EPS) of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.83, with a year-on-year change of -42.85.

What is the net income of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its net income was -113.62M, with a year-on-year change of -64.69.

What is the net margin of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its net profit margin was -1136.25, with a year-on-year change of -74.37.

What is the Return on Equity (ROE) of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -11.48, with a year-on-year change of -13.74.

What is the Return on Assets (ROA) of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -11.02, with a year-on-year change of -15.10.

What is the operating profit of Janux Therapeutics Inc?

According to Janux Therapeutics Inc's FY2025 earnings report, its operating profit was -157.67M, with a year-on-year change of -59.51.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.